Darko Kocjan

723 total citations
41 papers, 608 citations indexed

About

Darko Kocjan is a scholar working on Molecular Biology, Spectroscopy and Organic Chemistry. According to data from OpenAlex, Darko Kocjan has authored 41 papers receiving a total of 608 indexed citations (citations by other indexed papers that have themselves been cited), including 15 papers in Molecular Biology, 14 papers in Spectroscopy and 11 papers in Organic Chemistry. Recurrent topics in Darko Kocjan's work include Analytical Chemistry and Chromatography (7 papers), Mass Spectrometry Techniques and Applications (6 papers) and Analytical Methods in Pharmaceuticals (5 papers). Darko Kocjan is often cited by papers focused on Analytical Chemistry and Chromatography (7 papers), Mass Spectrometry Techniques and Applications (6 papers) and Analytical Methods in Pharmaceuticals (5 papers). Darko Kocjan collaborates with scholars based in Slovenia, China and Hungary. Darko Kocjan's co-authors include D. Hadži, Lennart Bergström, Giovanni Camino, Federico Carosio, Bernd Wicklein, Franc Avbelj, Robert L. Baldwin, U. Urleb, Adolf Miklavc and J. Kidrič and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of the American Chemical Society and Chemistry of Materials.

In The Last Decade

Darko Kocjan

39 papers receiving 584 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Darko Kocjan Slovenia 14 206 128 116 83 75 41 608
Ratna S. Phadke India 14 283 1.4× 66 0.5× 107 0.9× 50 0.6× 44 0.6× 63 640
G. Fini Italy 18 284 1.4× 99 0.8× 161 1.4× 74 0.9× 31 0.4× 37 752
Bertrand Blankert Belgium 16 226 1.1× 133 1.0× 111 1.0× 57 0.7× 54 0.7× 39 790
Paul A. Harmon United States 17 313 1.5× 202 1.6× 132 1.1× 203 2.4× 14 0.2× 34 1.0k
Dominic P. O′Brien United Kingdom 9 383 1.9× 140 1.1× 214 1.8× 127 1.5× 11 0.1× 11 693
J. S. Mandeville Canada 11 627 3.0× 60 0.5× 147 1.3× 95 1.1× 146 1.9× 14 781
Joanna Makowska Poland 15 499 2.4× 153 1.2× 102 0.9× 143 1.7× 14 0.2× 53 763
Usharani Subuddhi India 16 241 1.2× 129 1.0× 206 1.8× 178 2.1× 38 0.5× 35 762
Guy Dodin France 15 585 2.8× 93 0.7× 213 1.8× 130 1.6× 52 0.7× 49 990
Zahra Aliakbar Tehrani Iran 13 145 0.7× 71 0.6× 146 1.3× 139 1.7× 16 0.2× 36 546

Countries citing papers authored by Darko Kocjan

Since Specialization
Citations

This map shows the geographic impact of Darko Kocjan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Darko Kocjan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Darko Kocjan more than expected).

Fields of papers citing papers by Darko Kocjan

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Darko Kocjan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Darko Kocjan. The network helps show where Darko Kocjan may publish in the future.

Co-authorship network of co-authors of Darko Kocjan

This figure shows the co-authorship network connecting the top 25 collaborators of Darko Kocjan. A scholar is included among the top collaborators of Darko Kocjan based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Darko Kocjan. Darko Kocjan is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Sosič, Izidor, Martina Gobec, Marija Ivanov, et al.. (2020). Pyridylethanol(phenylethyl)amines are non-azole, highly selective Candida albicans sterol 14α-demethylase inhibitors. Bioorganic Chemistry. 106. 104472–104472. 8 indexed citations
2.
Perdih, Andrej, Martina Hrast, Hélène Barreteau, et al.. (2015). Furan-based benzene mono- and dicarboxylic acid derivatives as multiple inhibitors of the bacterial Mur ligases (MurC–MurF): experimental and computational characterization. Journal of Computer-Aided Molecular Design. 29(6). 541–560. 22 indexed citations
3.
Kristan, Katja, et al.. (2014). A novel 2-oxoindolinylidene inhibitor of bacterial MurD ligase: Enzyme kinetics, protein-inhibitor binding by NMR and a molecular dynamics study. European Journal of Medicinal Chemistry. 83. 92–101. 10 indexed citations
4.
Ačimovič, Jure, Ingemar Björkhem, Katalin Monostory, et al.. (2010). Inhibition of Human Sterol Δ7-Reductase and Other Postlanosterol Enzymes by LK-980, a Novel Inhibitor of Cholesterol Synthesis. Drug Metabolism and Disposition. 39(1). 39–46. 11 indexed citations
5.
Kuzman, Drago, et al.. (2009). Modulation of hepatic transcriptome in the poloxamer p-407 hyperlipidemia mouse model. Acta chimica slovenica. 56(1). 262–269. 2 indexed citations
6.
Grdadolnik, Simona Golič, Stanko Hočevar, Darko Kocjan, et al.. (2009). Amlodipine Benzenesulfonate: A Mechanistic Investigation of Its Industrial Preparation via Detritylation of N-tritylamlodipine and Related NMR Studies. Croatica Chemica Acta. 82(1). 299–309. 1 indexed citations
7.
Plavec, Janez, et al.. (2009). Isolation and structure determination of oxidative degradation products of atorvastatin. Journal of Pharmaceutical and Biomedical Analysis. 50(5). 729–736. 23 indexed citations
8.
Monostory, Katalin, Jean‐Marc Pascussi, Pál Szabó, et al.. (2008). Drug Interaction Potential of 2-((3,4-Dichlorophenethyl)(propyl)amino)-1-(pyridin-3-yl)ethanol (LK-935), the Novel Nonstatin-Type Cholesterol-Lowering Agent. Drug Metabolism and Disposition. 37(2). 375–385. 17 indexed citations
9.
Ačimovič, Jure, et al.. (2007). Novel cholesterol biosynthesis inhibitors targeting human lanosterol 14α-demethylase (CYP51). Bioorganic & Medicinal Chemistry. 16(1). 209–221. 32 indexed citations
10.
Grdadolnik, Jože, et al.. (2005). Synthesis, Conformation, and Stereodynamics of a Salt of 2-{[2-(3,4-Dichlorophenyl)- ethyl]propylamino}-1-pyridin-3-ylethanol. The Journal of Organic Chemistry. 71(2). 792–795. 4 indexed citations
11.
Avbelj, Franc, Darko Kocjan, & Robert L. Baldwin. (2004). Protein chemical shifts arising from α-helices and β-sheets depend on solvent exposure. Proceedings of the National Academy of Sciences. 101(50). 17394–17397. 64 indexed citations
12.
13.
Kocjan, Darko, et al.. (2001). Effect of column temperature on the behaviour of some angiotensin converting enzyme inhibitors during high-performance liquid chromatographic analysis. Journal of Chromatography B Biomedical Sciences and Applications. 755(1-2). 229–235. 26 indexed citations
14.
Kralj, Bogdan, Darko Kocjan, & J. Kobe. (2001). Reactivity of anomeric 1α‐ and 1β‐pentofuranosyl azide derivatives in ammonia chemical ionization. Rapid Communications in Mass Spectrometry. 15(8). 551–562. 3 indexed citations
15.
Kralj, Bogdan, Dušan Žigon, Darko Kocjan, & J. Kobe. (1997). Metastable and Collision-activated Decomposition of Protonated Molecules of Isomeric N7- and N9-Substituted Purines in the Gas Phase. Rapid Communications in Mass Spectrometry. 11(3). 273–282. 5 indexed citations
16.
Kocjan, Darko. (1994). On the interaction of the aromatic part of dopaminergic agonists with the receptor. Journal of Medicinal Chemistry. 37(18). 2851–2855. 6 indexed citations
17.
18.
Kocjan, Darko, et al.. (1988). Ab initio calculations on the hydration of dimethylpyrazole and indazole. Solvent effects on tautomeric energies.. Journal of Molecular Structure THEOCHEM. 165(1-2). 115–124. 8 indexed citations
19.
Kocjan, Darko, Milan Hodošček, & D. Hadži. (1986). Dopaminergic pharmacophore of ergoline and its analogs. A molecular electrostatic potential study. Journal of Medicinal Chemistry. 29(8). 1418–1423. 12 indexed citations
20.
Kocjan, Darko & D. Hadži. (1983). Conformationally restricted dopamine congeners—a molecular mechanics-based study. Journal of Pharmacy and Pharmacology. 35(12). 780–785. 3 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Ratna S. Phadke Breakdown of academic impact, for papers by G. Fini Breakdown of academic impact, for papers by Bertrand Blankert Breakdown of academic impact, for papers by Paul A. Harmon Breakdown of academic impact, for papers by Dominic P. O′Brien Breakdown of academic impact, for papers by J. S. Mandeville Breakdown of academic impact, for papers by Joanna Makowska Breakdown of academic impact, for papers by Usharani Subuddhi Breakdown of academic impact, for papers by Guy Dodin Breakdown of academic impact, for papers by Zahra Aliakbar Tehrani
Rankless by CCL
2026